Status:
WITHDRAWN
Platelet Function Testing Help and Intraoperative Bleeding Risk for Patients Who Are on Plavix Prior to Surgery
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Perioperative Bleeding
Eligibility:
All Genders
18+ years
Brief Summary
A large number of patients are currently on Antiplatelet inhibition using aspirin or Plavix therapy (A Thieno pyridine - ADP mediated platelet inhibitor). A group of these patients often require Cardi...
Eligibility Criteria
Inclusion
- All consenting participants who are taking plavix prior to undergoing vascular or cardiac surgery.
Exclusion
- All consenting participants who are NOT taking plavix prior to undergoing vascular or cardiac surgery.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00653900
Start Date
April 1 2008
End Date
June 3 2009
Last Update
November 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048